Germany-headquartered biomaterial developer AMSilk has secured €52 million in financing, which will be used to help it scale up.

AMSilk's technology reprogrammes microorganisms to produce biodegradable silk-based proteins, which can be processed into a variety of forms, including powders, hydrogels, fibres and coatings, and are used to produce a new class of fibres for textile applications.

Share this story: